Conference Coverage

Making naloxone available to patients at risk for opioid overdoses

Publish date: January 10, 2015

 

EXPERT ANALYSIS FROM THE AAAP ANNUAL MEETING

References

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

Brain changes identified in chronic fatigue syndrome
MDedge Psychiatry
FDA approves extended-release hydrocodone with abuse-deterrent features
MDedge Psychiatry
Use PEARLS to build relationships with patients
MDedge Psychiatry
Take these five key steps to limit reimbursement headaches
MDedge Psychiatry
Dihydroergotamine has a key role in migraine and daily headache, despite its underuse
MDedge Psychiatry
Anxiety disorders drive, worsen migraine symptoms
MDedge Psychiatry
VIDEO: Ask epilepsy patients about opioid use
MDedge Psychiatry
Most primary care physicians understand opioid risks
MDedge Psychiatry
Higher opioid doses associated with increase in depression
MDedge Psychiatry
Open wide: new insights into burning mouth syndrome
MDedge Psychiatry